drugset / Trial / NCT05966324
Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this study is to compare the characteristics of baxdrostat (CIN-107) in terms of baxdrostat levels over time in the blood in healthy Japanese and Caucasian volunteer participants.
Timeline
- Start
- 2022-07-05
- Primary completion
- 2022-09-20
- Completion
- 2022-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baxdrostat | Small molecule | 1 mg | Oral |
| Subject | Baxdrostat | Small molecule | 3 mg | Oral |
| Subject | Baxdrostat | Small molecule | 10 mg | Oral |